Drug recall · June 1, 2022
Losartan HCTZ 100/25 mg recall
Why: CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Losartan HCTZ 100/25 mg, 90 count bottles NDC# 70518-2578-00 Repackaged NDC Original NDC # 68180-0217-09
- Lots / codes
Lot # B1329507-082921, exp. date 08/31/2022 B1348363-091421, exp. date 09/30/2022 B1387286-101021, exp. date 10/31/2022 B1390974-101221, exp. date 10/31/2022 B1426010-110521, exp. date 11/30/2022
- Quantity
- 26/90 count bottles = 2,340 tablets
- Company
- RemedyRepack Inc., Indiana, PA
- Distribution
- Product was distributed to FL, SC and VA
- Initiated
- May 2, 2022 · Voluntary: Firm initiated
- Classified
- May 20, 2022
- Reported
- June 1, 2022
- Ended
- September 2, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Hydrochlorothiazide / losartan
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.